Pictet Asset Management Holding Sa Vertex Pharmaceuticals Inc Transaction History
Pictet Asset Management Holding Sa
- $88.9 Billion
- Q4 2024
A detailed history of Pictet Asset Management Holding Sa transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 519,668 shares of VRTX stock, worth $236 Million. This represents 0.24% of its overall portfolio holdings.
Number of Shares
519,668
Previous 518,003
0.32%
Holding current value
$236 Million
Previous $241 Million
13.13%
% of portfolio
0.24%
Previous 0.27%
Shares
6 transactions
Others Institutions Holding VRTX
# of Institutions
1,717Shares Held
223MCall Options Held
1.64MPut Options Held
1.37M-
Capital World Investors Los Angeles, CA26.8MShares$12.2 Billion1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.3MShares$10.5 Billion0.17% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$9.66 Billion0.23% of portfolio
-
State Street Corp Boston, MA11.8MShares$5.36 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA9MShares$4.08 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $116B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...